BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 27837632)

  • 1. Patterns of failure after involved field radiotherapy for locally advanced esophageal squamous cell carcinoma.
    Li DJ; Li HW; He B; Wang GM; Cai HF; Duan SM; Liu JJ; Zhang YJ; Cui Z; Jiang H
    J BUON; 2016; 21(5):1268-1273. PubMed ID: 27837632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elective nodal irradiation or involved-field irradiation in definitive chemoradiotherapy for esophageal squamous cell cancer: a retrospective analysis in clinical N0 patients.
    Sun Y; Zhang XL; Mao QF; Liu YH; Kong L; Li MH
    Curr Oncol; 2018 Oct; 25(5):e423-e429. PubMed ID: 30464693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.
    Zhang X; Li M; Meng X; Kong L; Zhang Y; Wei G; Zhang X; Shi F; Hu M; Zhang G; Yu J
    Radiat Oncol; 2014 Feb; 9():64. PubMed ID: 24571804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of involved-field conformal radiotherapy for cervical and upper-thoracic esophageal cancer.
    Ma JB; Song YP; Yu JM; Zhou W; Cheng EC; Zhang XQ; Kong L
    Onkologie; 2011; 34(11):599-604. PubMed ID: 22104156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of involved field radiotherapy and elective nodal irradiation in combination with concurrent chemotherapy for T1bN0M0 esophageal cancer.
    Nakatani Y; Kato K; Shoji H; Iwasa S; Honma Y; Takashima A; Ushijima T; Ito Y; Itami J; Boku N
    Int J Clin Oncol; 2020 Jun; 25(6):1098-1104. PubMed ID: 32189155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target volume delineation for radical radiotherapy of early oesophageal carcinoma in elderly patients.
    Su J; Zhu S; Liu Z; Zhao Y; Song C
    Cancer Radiother; 2017 Feb; 21(1):34-39. PubMed ID: 28041813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term clinical outcome of intensity-modulated radiation therapy for locally advanced esophageal squamous cell carcinoma.
    Ge X; Yang X; Lu X; Wen W; Zhen F; Ye H; Zhu H; Cao Y; Zhang S; Cheng H; Ma J; Yang B; Dai S; Guo Q; Cai J; Sun X
    Tumori; 2015; 101(2):168-73. PubMed ID: 25791535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of Elective Nodal Irradiation (ENI) and Involved Field Irradiation (IFI) in Radiotherapy for the Elderly Patients (Aged ≥ 70 Years) with Esophageal Squamous Cell Cancer: A Retrospective Analysis from a Single Institute.
    Jing W; Zhu H; Guo H; Zhang Y; Shi F; Han A; Li M; Kong L; Yu J
    PLoS One; 2015; 10(12):e0143007. PubMed ID: 26636574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of failure associated with involved field radiotherapy in patients with clinical stage I thoracic esophageal cancer.
    Kawaguchi Y; Nishiyama K; Miyagi K; Suzuki O; Ito Y; Nakamura S
    Jpn J Clin Oncol; 2011 Aug; 41(8):1007-12. PubMed ID: 21665908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involved-field radiotherapy (IFRT) versus elective nodal irradiation (ENI) in combination with concurrent chemotherapy for 239 esophageal cancers: a single institutional retrospective study.
    Yamashita H; Takenaka R; Omori M; Imae T; Okuma K; Ohtomo K; Nakagawa K
    Radiat Oncol; 2015 Aug; 10():171. PubMed ID: 26269033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node metastasis in sinonasal squamous cell carcinoma treated with IMRT/3D-CRT.
    Guan X; Wang X; Liu Y; Hu C; Zhu G
    Oral Oncol; 2013 Jan; 49(1):60-5. PubMed ID: 22884302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma.
    Hsu FM; Lee JM; Huang PM; Lin CC; Hsu CH; Tsai YC; Lee YC; Chia-Hsien Cheng J
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e593-9. PubMed ID: 21658851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of elective nodal irradiation and involved-field irradiation in esophageal squamous cell carcinoma: a meta-analysis.
    Cheng YJ; Jing SW; Zhu LL; Wang J; Wang L; Liu Q; Yang CR; Wang Y; Cao F; Jiao WP; Wu YJ
    J Radiat Res; 2018 Sep; 59(5):604-615. PubMed ID: 30085197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elective nodal irradiation provides a superior therapeutic modality for lymph node positivity esophageal squamous cell carcinoma patients receiving definitive radiotherapy versus involved-field irradiation.
    Li Q; Zhu S; Li S; Deng W
    Medicine (Baltimore); 2019 Jan; 98(3):e14080. PubMed ID: 30653123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of failure and clinical outcomes of definitive radiotherapy for cervical esophageal cancer.
    Zhao L; Zhou Y; Mu Y; Chai G; Xiao F; Tan L; Lin SH; Shi M
    Oncotarget; 2017 Mar; 8(13):21852-21860. PubMed ID: 28423530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involved-field radiotherapy for esophageal squamous cell carcinoma: theory and practice.
    Li M; Zhang X; Zhao F; Luo Y; Kong L; Yu J
    Radiat Oncol; 2016 Feb; 11():18. PubMed ID: 26846932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the value of ENI in radiotherapy for cervical and upper thoracic esophageal cancer: a retrospective analysis.
    Liu M; Zhao K; Chen Y; Jiang GL
    Radiat Oncol; 2014 Oct; 9():232. PubMed ID: 25344056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involved-Field Irradiation in Definitive Chemoradiotherapy for Locoregional Esophageal Squamous Cell Carcinoma: Results From the ESO-Shanghai 1 Trial.
    Zhu H; Rivin Del Campo E; Ye J; Simone CB; Zhu Z; Zhao W; Amini A; Zhou J; Wu C; Tang H; Fan M; Li L; Lin Q; Xia Y; Li Y; Li J; Mo M; Jia H; Lu S; Wang J; Nie Y; Chen J; Wu S; Hamaji M; Haque W; Jeong BK; Shridhar R; Zhang Z; Chen Y; Zhao K
    Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1396-1406. PubMed ID: 33677048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical outcomes of different irradiation ranges in definitive intensity-modulated radiotherapy for esophageal cancer].
    Zhu SC; Li QF; Zhang XY; Deng WZ; Song CY; Wang X; Yan K
    Zhonghua Zhong Liu Za Zhi; 2020 Dec; 42(12):1040-1047. PubMed ID: 33342161
    [No Abstract]   [Full Text] [Related]  

  • 20. Details of recurrence sites after elective nodal irradiation (ENI) using 3D-conformal radiotherapy (3D-CRT) combined with chemotherapy for thoracic esophageal squamous cell carcinoma--a retrospective analysis.
    Yamashita H; Okuma K; Wakui R; Kobayashi-Shibata S; Ohtomo K; Nakagawa K
    Radiother Oncol; 2011 Feb; 98(2):255-60. PubMed ID: 21074880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.